To see that HIF-1 is not only regulated by nobiletin treatment, but also plays a role in the nobiletin inhibition on VEGF expression, ovarian cancer cells were transfected with the VEGF-promoter reporter together with HIF-1 plasmids. This evidence concerns the gene HIF1A and ovarian carcinoma.